Upcoming event

Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses

  • Pfister C.,
  • Gravis G.,
  • Flechon A.,
  • Soulie M.,
  • Guy L.,
  • Laguerre B.,
  • Mottet N.,
  • Joly F.,
  • Allory Y.,
  • Harter V.,
  • Culine S.,
  • GETUG AFU V05 Investigators